Directors apply quantitative approaches to characterize clinical pharmacokinetics and pharmacodynamics of new chemical entities and biologics, inform dose selection and regulatory strategies to support global submissions and post-approval expansions.
Base: $190,800.00 - $300,300.00; Bonus/Equity: Eligible for annual bonus and long-term incentive; Benefits: Medical, dental, vision, retirement, paid holidays, vacation, sick days
Must-have
Nice-to-have
US and Puerto Rico Residents Only
Sponsorship: available